Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial.
Stinne HøghHanne Kristine HegaardKristina Martha RenaultEleonora CvetanovskaAnette Kjærbye-ThygesenAnders JuulCamilla BorgstedAnne Juul BjertrupKamilla Woznica MiskowiakMette Skovgaard VæverDea Siggaard StenbækVibeke Høyrup DamElisabeth BinderBrice OzenneDivya MehtaVibe G FrøkjærPublished in: BMJ open (2021)
NCT04685148.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- phase ii
- phase iii
- polycystic ovary syndrome
- study protocol
- randomized controlled trial
- phase ii study
- depressive symptoms
- pregnancy outcomes
- open label
- sleep quality
- cervical cancer screening
- breast cancer risk
- squamous cell carcinoma
- adipose tissue
- physical activity
- insulin resistance
- radiation therapy
- metabolic syndrome